Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure.
Flanagan E, Gibson PR, Wright EK, Moore GT, Sparrow MP, Connell W, Kamm MA, Begun J, Christensen B, De Cruz P, Shelton E, Dowling D, Andrews JM, Brown SJ, Niewiadomski O, Ward MG, Rosella O, Rosella G, Kiburg KV, Ross AL, Bell SJ; PICCOLO Study Group.
Flanagan E, et al. Among authors: christensen b.
Aliment Pharmacol Ther. 2020 Nov;52(10):1551-1562. doi: 10.1111/apt.16102. Epub 2020 Sep 27.
Aliment Pharmacol Ther. 2020.
PMID: 32981127